Trial intelligence / Profile preview

Gabapentin and Pregabalin for pain reduction after PRK

IRCT1138901211180N12Phase 3Completed

Sponsor
Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences
Start
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of gabapentin and pregabalin in ametropia and postoperative pain (2 arms), sponsored by Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences. Primary endpoint: Postoperative pain reduction. Started Mar 2010; status: completed.

02

Drugs

gabapentinpregabalin
03

Conditions

ametropiapostoperative pain

Beyond the preview

Go deeper on IRCT1138901211180N12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT1138901211180N12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call